Clinical Outcomes

Treatment Outcomes
& Clinical Results

Anonymized aggregate data from over 900 patients treated at MindScape Retreat since 2019. Unprecedented transparency for ibogaine treatment outcomes.

900+
Patients Treated
Since 2019
Zero
Medical Complications
With full cardiac screening
40+
Countries Represented
Worldwide
5+
Years Operating
Continuous clinical experience

Patient Distribution

Conditions Treated

Breakdown of 900+ patients by primary presenting condition. Many patients present with co-occurring conditions.

Opioid & Fentanyl Addiction340+ patients (38%)
Alcohol Use Disorder145+ patients (16%)
Depression & Anxiety125+ patients (14%)
PTSD, CPTSD & TBI100+ patients (11%)
Parkinson's Disease100+ patients (11%)
Stimulant Addiction35+ patients (4%)
Other Conditions55+ patients (6%)

Clinical Efficacy

Outcome Rates by Condition

Self-reported and clinically assessed outcomes at 12-month follow-up. Rates are highest among patients who complete the full 90-day integration program.

72%Opioid Addiction

Sustained freedom at 12-month follow-up (with integration)

68%Alcohol Use Disorder

Significant reduction or cessation at 12 months

74%Depression (Treatment-Resistant)

Clinically meaningful symptom reduction

70%PTSD & Trauma

Reduced severity on standardized measures

62%Parkinson's Motor Symptoms

Average motor improvement (UPDRS scale)

78%SSRI Discontinuation

Successful medication-free transition

Neuroregeneration Program

Parkinson's Disease Outcomes

MindScape has treated 100+ Parkinson's patients — the largest known clinical dataset for ibogaine-assisted treatment of Parkinson's disease worldwide.

62%
Motor Improvement (avg)
86%
Gait Improvement (avg)
54%
Tremor Reduction (avg)
91%
Quality of Life (self-reported)

Our 14–18 day Parkinson's neuroregeneration protocol targets tremor, rigidity, and gait dysfunction under daily physician supervision. Outcomes are measured using the Unified Parkinson's Disease Rating Scale (UPDRS) and patient self-assessment. Results vary by disease stage and individual response. Learn more about our Parkinson's program.

Safety & Medical Protocols

Zero Complications. Full Cardiac Screening.

900+
Patients screened and treated

Every patient undergoes comprehensive cardiac evaluation including EKG before admission

0
Medical complications

Zero serious adverse events across 5+ years of continuous clinical operation

100%
Cardiac screening compliance

No exceptions. EKG + bloodwork + physician intake for every patient, every time

24/7
Physician supervision

Board-certified physician and trained nurse present throughout every treatment session

Post-Treatment

Integration & Follow-Through

Integration is where lasting transformation takes root. These rates reflect patient engagement with our 90-day post-treatment program.

Complete 90-day integration program73%
Attend all scheduled coaching calls68%
Active in alumni community at 6 months61%
Report sustained outcomes at 12 months71%

Global Reach

Where Our Patients Come From

MindScape Retreat draws patients from over 40 countries. Regional breakdown by percentage of total patients.

United States52%
Canada18%
United Kingdom9%
Australia & NZ6%
Europe (other)8%
Rest of World7%

Methodology & Disclaimer

All data presented on this page represents anonymized, aggregate outcomes from MindScape Retreat's clinical records spanning 2019–2026. No individual patient data is displayed or identifiable.

Outcome rates are based on patient self-reporting and clinician assessment at scheduled follow-up intervals (30 days, 90 days, 6 months, and 12 months post-treatment). Not all patients complete all follow-up intervals. Reported rates reflect patients who responded to follow-up contact.

Success rates are highest among patients who complete the full 90-day integration program. Individual results vary based on condition severity, treatment history, co-occurring conditions, and engagement with post-treatment protocols.

These figures are observational and not derived from randomized controlled trials. MindScape Retreat is committed to contributing to the growing body of clinical evidence for ibogaine-assisted treatment. For questions about our data collection methodology, contact info@mindscaperetreat.com.

Take the First Step

Your Transformation Starts Here

See if you're a candidate with our confidential self-assessment, or speak directly with our medical team.

Take Self-AssessmentBook Free Consultation
WhatsApp Us NowCall +1 786-761-7729

100% Confidential · No Obligation · Available 7 Days a Week

Start a Confidential Conversation

100% Confidential · No Obligation · Response Within 24 Hours